American Society of Clinical Oncology

SHERPA: White

People

  1. D'Angelo
    D'Angelo
  2. Dickson
    Dickson
  3. Gounder
    Gounder
  4. Keohan
    Keohan
  5. Landa
    Landa
  6. Tap
    Tap
  7. Antonescu
    Antonescu
  8. Crago
    Crago
  9. Qin
    Qin
  10. Singer
    Singer

Groups

  1. Body Imaging Service (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Molecular Imaging and Therapy Service (4)
  5. Radiology, Department of (4)
  6. Sarcoma Service (4)
  7. Solid Tumor Oncology Division (4)
  8. Biostatistics Service (3)
  9. Epidemiology and Biostatistics (3)
  10. GSK Faculty (3)
Search Within
  1. "Sandra D'Angelo"
  2. "Jonathan Landa"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Body Imaging Service (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Molecular Imaging and Therapy Service (4)
  5. Radiology, Department of (4)
  6. Sarcoma Service (4)

More Groups

People
  1. Jonathan Landa (4)
  2. Mark Dickson (4)
  3. Mary Keohan (4)
  4. Mrinal Gounder (4)
  5. Sandra D'Angelo (4)
  6. William Tap (4)

More People

Years
  1. 2019 (1)
  2. 2015 (1)
  3. 2013 (2)
Publications
  1. Journal of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Metastatic non-uterine leiomyosarcoma: Prognostic factors, overall survival and chemotherapy outcomes
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Landa, J.; Kuk, D.; Sanchez, A. J.; Lala, B.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Tap, W. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
    Journal Article

    Dickson, M. A.; Tap, W. D.; Keohan, M. L.; D'Angelo, S. P.; Gounder, M. M.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Rathbone, D. D.; Condy, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save